Rachel M. Terry, NP

Rachel Terry practices at Blount Memorial Physician Group, Inc. in Maryville, Tennessee.

Rachel Terry's NPI, 1700517885, was assigned on June 21, 2022. Rachel Terry holds Tennessee license 31886.

Rachel Terry's primary practice is Blount Memorial Physician Group, Inc., at 103 W Broadway Ave, Maryville, TN 37801 in Blount County. The practice phone is (865) 984-3864.

Rachel Terry's primary practice is Blount Memorial Physician Group, Inc. in Maryville, Tennessee. Rachel Terry is also affiliated with Prisma Health Blount Memorial Hospital. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Rachel Terry to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachel Terry practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Rachel Terry's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Rachel Terry is licensed in Tennessee.

CMS counts 142 Medicare patients who saw Rachel Terry in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachel Terry's median patient age at 65, with 56% women.

In 2024, Rachel Terry wrote 121 Medicare Part D claims for 70 patients. 95% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Rachel Terry for performance year 2024, reported through an alternative payment model (APM). Rachel Terry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Rachel Terry from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Vertex Pharmaceuticals Incorporated paid the most, $39.